BridgeBio Oncology Therapeutics BBOT
NASDAQ BBOT
$3.97 +0.03 (+0.76%)
As of: Oct 2, 2026 · 11:18 AM EDT

BridgeBio Oncology Therapeutics (BBOT) Non-Interest Income (2024 - 2025)

Updated

BridgeBio Oncology Therapeutics' Non-Interest Income was $1,159 in Q2 2025, down 52.6% from the prior quarter.

Analysis

BridgeBio Oncology Therapeutics (BBOT) Non-Interest Income (2024 - 2025) Analysis & Trends

On a trailing twelve-month basis, BridgeBio Oncology Therapeutics' Non-Interest Income was $9,786 through Jun 30, 2025; for FY2024, it was $6,182.

  • Per Business Quant data, BBOT's Non-Interest Income in the three quarters before Q2 2025 was $2,445 (Q1 2025), $3,182 (Q4 2024) and $3,000 (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Interest Income (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 BridgeBio Oncology Therapeutics 328.47 Mn -1.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1,159.00
Mar 31, 2025 2,445.00
Dec 31, 2024 3,182.00
Sep 30, 2024 3,000.00
API Access

BridgeBio Oncology Therapeutics Non-Interest Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-interest-income&ticker=BBOT&period=max&api_key=YOUR_API_KEY